BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF

Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease

(2017) Sid E. O'Bryant et al.   JOURNAL OF ALZHEIMERS DISEASE

BDNFVal66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease

(2016) Yen Ying Lim et al.   BRAIN

Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory

(2015) Ana Kim et al.   COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE

Development of mature BDNF-specific sandwich ELISA

(2015) Yoon Lim et al.   JOURNAL OF NEUROCHEMISTRY

CREB expression mediates amyloid β-induced basal BDNF downregulation

(2015) Elyse Rosa et al.   NEUROBIOLOGY OF AGING

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease

(2014) Y Y Lim et al.   MOLECULAR PSYCHIATRY

Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer’s Disease: A Preliminary Study

(2014) Yen Ying Lim et al.   PLoS One

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease

(2013) Yen Ying Lim et al.   BRAIN

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

(2013) Bai Lu et al.   NATURE REVIEWS NEUROSCIENCE

BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease

(2013) Yen Ying Lim et al.   NEUROBIOLOGY OF AGING

miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model

(2012) Soon-Tae Lee et al.   ANNALS OF NEUROLOGY

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

(2011) Victor L. Villemagne et al.   ANNALS OF NEUROLOGY

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

(2011) Christopher M. Clark   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

(2010) Rik Vandenberghe et al.   ANNALS OF NEUROLOGY

Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels

(2010) F. Angelucci et al.   Current Alzheimer Research

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients

(2010) Christoph Laske et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)

(2010) D. F. Wong et al.   JOURNAL OF NUCLEAR MEDICINE

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

(2010) Christopher C. Rowe et al.   NEUROBIOLOGY OF AGING

CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease

(2010) A. Caccamo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment

(2010) Orestes Vicente Forlenza et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

(2009) Kathryn A Ellis et al.   INTERNATIONAL PSYCHOGERIATRICS

Association Study of the Decreased Serum BDNF Concentrations in Amnestic Mild Cognitive Impairment and the Val66Met Polymorphism in Chinese Han

(2009) Hui Yu et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations

(2009) U E Lang et al.   MOLECULAR PSYCHIATRY